07/News & Events
Follow the build.
Press releases
- September 14, 2026Etienna Bio Completes FDA INTERACT Meeting for ETB-001
- February 11, 2026Etienna Bio Secures Exclusive Worldwide License from UMass Chan Medical School for Novel Adipose-Derived Regenerative Platform
- January 9, 2026Etienna Bio Secures Exclusive Worldwide License from UMass Chan Medical School for Novel Adipose-Derived Regenerative Platform
